Epidemiological studies on benefits and harms of drug treatment – special focus on drug safety in pregnancy and childhood.
The purpose of the study is to link data from health registries and some other data sources in five Nordic countries to investigate drug use in women of childbearing age, expectant fathers and children. Outcomes will be short-term and long-term effects in children after being exposed in utero or later in life, as well as consequences for the mother whether she continues or stops treatment while she is pregnant.
About the project
-
Project period: 01.01.2018 - 01.02.2032 (Active)
- Coordinating Institution: Norwegian Institute of Public Health
-
Project Manager:
- Kari Furu, Norwegian Institute of Public Health
-
Project Participants:
- Inger Johanne Landsjøåsen Bakken, Centre for Fertility and Health, Norwegian Institute of Public Health
- Siri Eldevik Håberg, Centre for Fertility and Health, Norwegian Institute of Public Health
- Lars Jøran Kjerpeseth, Department of Chronic Diseases, Norwegian Institute of Public Health
- Vidar Hjellvik, Department of Chronic Diseases, Norwegian Institute of Public Health
- Jacqueline Mallory Cohen, Department of Chronic Diseases, Norwegian Institute of Public Health
- Randi Marie Selmer, Physical Health and Ageing, Norwegian Institute of Public Health
- Maria Christine Magnus, Centre for Fertility and Health, Norwegian Institute of Public Health
- Viktor Wintzell, Karolinska Institutet
- Bjørn Pasternak, Karolinska Institutet
- Helga Zoega, University of Iceland
- Mette Nørgaard, Aarhus University
- Helle Kieler, Karolinska Institutet
- Mika Gissler, National Institute for Health and Welfare
- Pär Karlsson, Karolinska Institutet
- Carolyn Cesta, Karolinska Institutet
- Eva Skovlund, Norwegian University of Science and Technology
- Kari Klungsøyr, Norwegian Institute of Public Health
- Øystein Karlstad, Norwegian Institute of Public Health
- Anders Engeland, Norwegian Institute of Public Health